- Home
- BZFD vs ASRT Comparison
BZFD vs ASRT Comparison
Compare BZFD & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- ASRT
- Stock Information
- Founded
- BZFD 2006
- ASRT 1995
- Country
- BZFD United States
- ASRT United States
- Employees
- BZFD 611
- ASRT N/A
- Industry
- BZFD Movies/Entertainment
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- BZFD Consumer Discretionary
- ASRT Health Care
- Exchange
- BZFD Nasdaq
- ASRT Nasdaq
- Market Cap
- BZFD 64.1M
- ASRT 79.1M
- IPO Year
- BZFD N/A
- ASRT 1997
- Fundamental
- Price
- BZFD $1.67
- ASRT $0.88
- Analyst Decision
- BZFD
- ASRT Strong Buy
- Analyst Count
- BZFD 0
- ASRT 1
- Target Price
- BZFD N/A
- ASRT $3.00
- AVG Volume (30 Days)
- BZFD 285.3K
- ASRT 323.8K
- Earning Date
- BZFD 11-11-2025
- ASRT 11-10-2025
- Dividend Yield
- BZFD N/A
- ASRT N/A
- EPS Growth
- BZFD N/A
- ASRT N/A
- EPS
- BZFD 0.25
- ASRT N/A
- Revenue
- BZFD $194,178,000.00
- ASRT $117,099,000.00
- Revenue This Year
- BZFD $6.87
- ASRT N/A
- Revenue Next Year
- BZFD $6.21
- ASRT $6.75
- P/E Ratio
- BZFD $6.66
- ASRT N/A
- Revenue Growth
- BZFD 1.38
- ASRT N/A
- 52 Week Low
- BZFD $1.61
- ASRT $0.51
- 52 Week High
- BZFD $5.68
- ASRT $1.16
- Technical
- Relative Strength Index (RSI)
- BZFD 30.91
- ASRT 51.53
- Support Level
- BZFD $1.66
- ASRT $0.87
- Resistance Level
- BZFD $1.80
- ASRT $0.93
- Average True Range (ATR)
- BZFD 0.07
- ASRT 0.04
- MACD
- BZFD 0.00
- ASRT -0.01
- Stochastic Oscillator
- BZFD 3.42
- ASRT 7.03
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.